Projects
Current Studies & Funders
-
Understanding the effect of atmospheric conditions on the survival and gene expression of aerosolised Group A Streptococcus (funded by European Society of Paediatric Infectious Diseases)
-
Group A streptococcal biology and immunopathogenesis in the upper respiratory tract (funded by Elizabeth Blackwell Institute)
-
Understanding respiratory pathogen antigenicity and immunodominance for the rational design of mucosal vaccines (funded by Elizabeth Blackwell Institute)
-
Characterisation of the mucosal immune response to Group A Streptococcus through development of a novel saliva immunoassay (funded by Elizabeth Blackwell Institute)
-
Systematic Review of Antibody Response to Group A Streptococcus
-
The GEMINI (Group A StreptococcusMucosal Immunity) Study (funded by Bristol and Weston Hospitals Charity)
-
Longitudinal antibody and cellular immune responses in individuals receiving the UK extended dosing interval regimen of the Pfizer/BioNTech BNT162b2 SARS-CoV-2 vaccine (funded by Elizabeth Blackwell Institute)
-
The LOGIC Study (LOnGItudinal Study of COVID-19): Symptoms, Virology & Immunity (funded by the Grand Appeal)
-
Measurement of salivary antibody responses to COVID-19 vaccinations in clinically at-risk patient groups (part of the OCTAVE trial) (National Institute for Health and Care Research, UKRI).
-
Measurement of salivary antibody responses in the ComFluCov trial (National Institute for Health and Care Research)
-
COVID-19 Mapping and Mitigation in Schools (Medical Research Council)
-
Characterisation of COVID-19 long term immunity in the ASLPAC cohort (Medical Research Council)
-
Exploration of salivary antibody responses following administration of an inactivated, adjuvanted SARS-CoV-2 virus vaccine candidate (VLA2001) using SARS-CoV-2 Spike and nucleocapsid protein IgA and IgG ELISAs (Valneva)